Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 1
2003 1
2004 2
2005 1
2006 2
2007 8
2008 8
2009 6
2010 6
2011 6
2012 6
2013 6
2014 5
2015 5
2016 6
2017 5
2018 3
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

PubMed Links for id: 114907

64 results
Results by year
Filters applied: . Clear all
Page 1
Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer.
Chou JL, Su HY, Chen LY, Liao YP, Hartman-Frey C, Lai YH, Yang HW, Deatherage DE, Kuo CT, Huang YW, Yan PS, Hsiao SH, Tai CK, Lin HJ, Davuluri RV, Chao TK, Nephew KP, Huang TH, Lai HC, Chan MW. Chou JL, et al. Lab Invest. 2010 Mar;90(3):414-25. doi: 10.1038/labinvest.2009.138. Epub 2010 Jan 11. Lab Invest. 2010. PMID: 20065949 Free PMC article.
64 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page